Ask About Adherence: Private-sector collaboration can lead to savings and care improvement
By Carolyn Ha | January 25, 2018
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recent study on medication non-adherence and discuss how a safe...
Read More
New report shows better diabetes management saves money and improves patient outcomes
By Carolyn Ha | November 21, 2017
A recent IHS Markit report, “The Clinical and Economic Benefits of Better Treatment of Adult Medicaid Beneficiaries with Diabetes,” simulated savings in the Medicaid program as a result of better...
Read More
Protect your health: Important disaster preparedness tips for Harvey and Irma
By Guest Contributor | September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs
By Robert Zirkelbach | April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...
Read More
10 years of living and managing type 1 diabetes; lessons learned
By Guest Contributor | November 30, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday: Progress in fight against diabetes is one more thing to be thankful for this year
By Nicole Longo | November 21, 2016
30 million. 1.4 million. 11 million. 86 million. These numbers on their own may mean nothing, but in the context of diabetes, they paint an entirely different picture. More than 30 million...
Read More
Reflecting on terrific progress in treating diabetes
By Bill Chin, M.D. | November 17, 2016
There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...
Read More
New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives
By Hannah Mooney | November 14, 2016
Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...
Read More
Burden on patients: Insurance benefit design’s impact on patient access to medicines
By Allyson Funk | June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...
Read More
New report celebrates a decade of progress in chronic diseases
By Holly Campbell | February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...
Read More
Medicare Monday (100)
340B Spotlight (33)
Cost & Consequence (0)
